Form 4: Medpace CFO Exercises Options and Sells Shares

Medpace Holdings, Inc. CFO & Treasurer Kevin M. Brady exercised stock options and subsequently sold a portion of the acquired shares.

Summary

• Medpace Holdings, Inc. CFO & Treasurer Kevin M. Brady engaged in two transactions on July 24, 2025.
• Brady exercised employee stock options to acquire 12,000 shares of common stock at an exercise price of $57.94 per share.
• Following this acquisition, Brady's direct beneficial ownership of common stock increased to 18,000 shares.
• Concurrently, Brady sold 12,000 shares of common stock at a weighted average price of $454.23 per share. Individual sale prices ranged from $449.25 to $461.24.
• After these transactions, Brady's direct beneficial ownership of Medpace Holdings, Inc. common stock is 6,000 shares.
• The employee stock option exercised vested in full on November 12, 2022.
• The sales were executed pursuant to a limit order placed during an open window period.

Sentiment

Score: 7

Explanation: The filing reports a routine executive transaction involving the exercise of stock options and a subsequent sale of shares, indicating the executive monetized a portion of their equity compensation at a high market price.

Positives

• CFO Kevin M. Brady realized a significant gain by exercising options at $57.94 and selling shares at a weighted average of $454.23, demonstrating the substantial value of his equity compensation.
• The high sale price of $454.23 per share reflects a strong market valuation for Medpace Holdings, Inc.

Negatives

• The sale of 12,000 shares by a key executive like the CFO could be interpreted by some investors as a signal of reduced confidence or a move to diversify personal holdings, potentially leading to negative sentiment.

Future Outlook

NA

Management Comments

• The transactions were effected pursuant to a limit order placed by the Reporting Person during an open window period.

Industry Context

A Form 4 filing primarily reports individual executive stock transactions and does not typically provide broader industry context or trends.

Stakeholder Impact

• Shareholders: May view the sale by a CFO as a slight negative, but it is a common practice for executives to diversify their personal holdings. The high sale price reflects positively on the company's valuation.

Key Dates

Recommendation

The filing details a standard executive transaction involving the exercise of stock options and a subsequent sale of shares for personal financial planning. While a sale by a CFO might raise questions, it appears to be a routine monetization of vested equity compensation at a favorable market price, not necessarily indicative of a change in company fundamentals or future prospects. Therefore, a 'hold' recommendation is appropriate as this single transaction does not provide sufficient new information to warrant a change in investment thesis.

Keywords

Medpace Holdings, MEDP, insider trading, stock options, CFO, share sale, Form 4, executive compensation